ADC Therapeutics SA Outperforms Medical Stocks This Year

ADC Therapeutics (ADCT) has outperformed the Medical sector this year, with a 8.2% year-to-date return compared to the sector's 7.5%. The stock has a Zacks Rank of #2 (Buy) and its full-year earnings estimates have risen 36.3% over the past 90 days. Agenus (AGEN) is another Medical stock that has outperformed the sector, with a 35.4% year-to-date return and a Zacks Rank of #2 (Buy).